HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Double de novo mutations of ELANE (ELA2) in a patient with severe congenital neutropenia requiring high-dose G-CSF therapy.

AuthorsLina Lundén, Sandra Boxhammer, Göran Carlsson, Karl-Gustav Ellström, Magnus Nordenskjöld, Kristina Lagerstedt-Robinson, Bengt Fadeel
JournalBritish journal of haematology (Br J Haematol) Vol. 147 Issue 4 Pg. 587-90 (Nov 2009) ISSN: 1365-2141 [Electronic] England
PMID19694719 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Granulocyte Colony-Stimulating Factor
  • Leukocyte Elastase
Topics
  • Base Sequence
  • Child
  • DNA Mutational Analysis (methods)
  • Granulocyte Colony-Stimulating Factor (therapeutic use)
  • Humans
  • Leukocyte Elastase (genetics)
  • Male
  • Mutation, Missense
  • Neutropenia (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: